A placebo-controlled study of sildenafil effects on cognition in schizophrenia.

Psychopharmacology
Donald C GoffJared Walsh

Abstract

Phosphodiesterase 5 (PDE5) inhibitors increase cyclic guanosine monophosphate (cGMP) concentrations in the intracellular pathway activated by N-methyl-D-aspartic acid receptors which is believed to mediate long-term potentiation and memory consolidation. The PDE5 inhibitor sildenafil has been shown to enhance memory in animal models. In addition, neuronal nitric oxide synthase, another component of the NMDA/nitric oxide/cGMP intracellular pathway, has been reported to be dysregulated in schizophrenia patients. Seventeen adult schizophrenia outpatients treated with a stable dose of antipsychotic received a single oral dose of placebo, sildenafil 50 mg, and sildenafil 100 mg in random order with a 48-h interval between administrations. Psychiatric symptom ratings and a cognitive battery were performed at baseline and 1 hour following each administration of the study drug. In addition, memory consolidation was examined by testing recall 48 h later, prior to the next administration of the study drug. Fifteen subjects completed all three treatment conditions. One subject developed irritability and required hospitalization 2 days after receiving sildenafil 100 mg. Neither dose of sildenafil significantly affected cognitive performanc...Continue Reading

References

Aug 1, 1997·Clinical Neuropharmacology·S I DeutschK Fearing
Apr 26, 2000·Behavioural Pharmacology·C M Baratti, M M Boccia
Sep 5, 2001·The American Journal of Psychiatry·D C Goff, J T Coyle
Feb 9, 2002·European Journal of Pharmacology·Jos PrickaertsArjan Blokland
Jun 28, 2002·The Annals of Pharmacotherapy·Harry A Milman, Suzanne B Arnold
Nov 2, 2002·Stroke; a Journal of Cerebral Circulation·Ruilan ZhangMichael Chopp
Nov 26, 2002·Nitric Oxide : Biology and Chemistry·Frank I TaraziRoss J Baldessarini
Mar 21, 2003·Nature·Yi NongMichael W Salter
Nov 12, 2003·The American Journal of Cardiology·Raymond C Rosen, John B Kostis
Nov 19, 2003·The Journal of Comparative Neurology·Wilma C G Van StaverenJan De Vente
Aug 18, 2004·Neurochemistry International·Jos PrickaertsArjan Blokland
Nov 25, 2004·Schizophrenia Research·Harri J TuominenKristian Wahlbeck
Jan 11, 2005·Physiology & Behavior·Andrew K HotchkissRandy J Nelson
Jan 22, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Slaven ErcegVicente Felipo
Feb 22, 2005·International Journal of Cardiology·Anand ChockalingamSmrita Dorairajan
Apr 12, 2005·Neurobiology of Learning and Memory·A Sophie ParnasRick Richardson
Jul 12, 2005·Schizophrenia Research·Hans-Gert BernsteinGerburg Keilhoff
Oct 20, 2005·PLoS Medicine·Sharon L Eastwood
Sep 14, 2006·Pharmacological Reviews·Andrew T Bender, Joseph A Beavo

❮ Previous
Next ❯

Citations

Oct 31, 2009·Nature Reviews. Drug Discovery·Herbert Y MeltzerPeter Kirkpatrick
Nov 25, 2011·Schizophrenia Bulletin·Richard S E KeefeMichelle Stewart
May 19, 2009·Annals of General Psychiatry·Shaheen E Lakhan, Karen F Vieira
Oct 9, 2013·Psychopharmacology·Ana C IssyElaine A Del-Bel
Aug 3, 2012·Psychopharmacology·O A H ReneerkensJ Prickaerts
Jul 22, 2011·Expert Opinion on Pharmacotherapy·Robert A KlonerVera J Stecher
Apr 23, 2011·Expert Opinion on Investigational Drugs·Niels PlathJohn Paul Redrobe
Apr 6, 2011·Pharmacology, Biochemistry, and Behavior·Tanya L WallaceJoseph G Wettstein
Dec 1, 2010·Pharmacology, Biochemistry, and Behavior·Donald C GoffDeanna Barch
Dec 27, 2015·Schizophrenia Research·Seong ShimErica Duncan
May 25, 2016·The Psychiatric Clinics of North America·Ganesh GopalakrishnaJohn Lauriello
Aug 23, 2011·Neuropharmacology·Joshua S RodeferSamuel J Eckrich
Feb 25, 2015·Current Opinion in Psychiatry·Donald C Goff
Aug 5, 2017·Expert Opinion on Investigational Drugs·Jos PrickaertsArjan Blokland
Dec 13, 2017·Oncotarget·Ines BaroneStefania Catalano
Aug 8, 2019·Nature Reviews. Drug Discovery·George S BaillieMichy P Kelly
Jan 17, 2021·Pharmaceuticals·Ernesto Fedele, Roberta Ricciarelli
Feb 15, 2020·Journal of Affective Disorders·Eduardo Duarte-SilvaChristina Peixoto

❮ Previous
Next ❯

Methods Mentioned

BETA
pregnancy test
sedation

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here